J&J, Medtronic Adapt To Changing Chinese Medical Device Market - Ernst &Young Report
This article was originally published in PharmAsia News
Executive Summary
As the Chinese government increases healthcare spending and the country's middle class rises to dominate the consumer market, global medical device makers are taking note. Johnson & Johnson and Medtronic are switching strategies to develop and market products that are tailored to the growing middle class
You may also be interested in...
Emerging Markets Earnings Roundup: Abbott, AbbVie, J&J And Novartis (Part 3)
In Part 3 of our feature, we take a closer look at the first quarterly calls for Abbott and AbbVie after the company split in two, plus the latest on emerging markets from J&J and Novartis.
Emerging Markets Earnings Roundup: Abbott, AbbVie, J&J And Novartis (Part 3)
In Part 3 of our feature, we take a closer look at the first quarterly calls for Abbott and AbbVie after the company split in two, plus the latest on emerging markets from J&J and Novartis.
SFDA Requires Chinese Labeling For Imported Medical Devices
New labeling could impact a range of multinational diagnostic and device companies, particularly those that import finished products.